Brainsway, a commercial stage medical device maker for the treatment of depression & OCD, filed on Monday with the SEC to raise up to $30 million in an initial public offering.
Brainsway has been listed on the Tel Aviv Stock Exchange under the ticker BRIN since 2007, and closed on Monday with a market cap of $97 million. In 2011 it launched a $10 million Nasdaq IPO, but later withdrew the offering.
The Jerusalem, Israel-based company was founded in 2006 and booked $15 million in sales for the 12 months ended September 30, 2018. It plans to list on the Nasdaq under the symbol BWAY. Brainsway filed confidentially on November 16, 2018. Cantor Fitzgerald is the sole bookrunner on the deal. No pricing terms were disclosed.
